circulating tumor DNA Feb 9, 2023 Startup mDetect Readying Trial of Methylation-Based Liquid Biopsy for Breast Cancers Premium Jan 26, 2023 Circulating Tumor DNA Testing Informs Best Second-Line Treatment for Gastrointestinal Stromal Tumors Premium Jan 24, 2023 New Study Results Boost Evidence for Natera's MRD Assays to Guide Adjuvant Therapy Decisions Premium Jan 19, 2023 Liquid Biopsy Biomarker Score Predicts Relapse in Lymphoma Patients After CAR T-Cell Treatment Premium Jan 19, 2023 Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer Jan 10, 2023 Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test Jan 5, 2023 AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform Dec 21, 2022 Guardant Health, Susan G. Komen Partner to Evaluate MRD Test in Breast Cancer Dec 15, 2022 Study Shows Value of Routine MRD Analysis Using Foresight's PhasED-Seq in Lymphoma Patients Premium Dec 12, 2022 NeoGenomics Growing Evidence Base for Residual Disease Assay in Breast Cancer Premium Nov 30, 2022 Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring Nov 28, 2022 SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test Oct 31, 2022 Epigenetic Signatures in Eye Predict Rare Tumor Aggressiveness, Treatment Response Premium Oct 26, 2022 Hedera Dx Hopes to Hasten Liquid Biopsy Adoption in Europe With Streamlined Platform Premium Oct 17, 2022 Singapore Institutions Launch Program to Diagnose, Treat EBV-Associated Nasopharyngeal Cancer Oct 13, 2022 Consortium Studying Children, Families to Understand Pediatric Cancer Risk, Tumor Development Premium Sep 11, 2022 Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Sep 1, 2022 Multiple Myeloma Researchers Chip Away at Why Some Patients Relapse Quickly After CAR T-Cell Therapy Premium Aug 8, 2022 Small Cell Lung Cancer Detection, Classification Achieved Using Cell-Free DNA Methylation Load More Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors
